Syndax Pharmaceuticals Shares Outstanding 2015-2021 | SNDX

Syndax Pharmaceuticals shares outstanding from 2015 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Syndax Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2020 41
2019 30
2018 25
2017 21
2016 15
2015 0
2014 0
Syndax Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 52
2021-03-31 52
2020-12-31 41
2020-09-30 44
2020-06-30 41
2020-03-31 34
2019-12-31 30
2019-09-30 32
2019-06-30 32
2019-03-31 27
2018-12-31 25
2018-09-30 25
2018-06-30 25
2018-03-31 24
2017-12-31 21
2017-09-30 22
2017-06-30 19
2017-03-31 18
2016-12-31 15
2016-09-30 18
2016-06-30 18
2016-03-31 5
2015-12-31 0
2015-09-30 0
2015-06-30 0
2015-03-31 0
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.914B $0.002B
Syndax Pharmaceuticals, Inc. is a biopharmaceutical company which focused on the development and commercialization of entinostat, an epigenetic therapy for treatment-resistant cancers. The Company's product pipeline includes ENCORE 601, ENCORE 602, J1353, NCI-7870, NCI-9844, E2112, NCI-8871 and NCI-9253 which are in clinical trial stage. Syndax Pharmaceuticals, Inc. is based in WALTHAM, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.838B 8.91
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.341B 20.90
Biohaven Pharmaceutical Holding (BHVN) United States $8.723B 0.00
Emergent Biosolutions (EBS) United States $2.813B 6.79
Arcus Biosciences (RCUS) United States $2.568B 0.00
Myovant Sciences (MYOV) United Kingdom $2.170B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.949B 0.00
Zymeworks (ZYME) Canada $1.323B 0.00
Ambrx Biopharma (AMAM) United States $0.509B 0.00
SQZ Biotechnologies (SQZ) United States $0.428B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29